Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.
Ng R, Manring H, Papoutsidakis N, Albertelli T, Tsai N, See CJ, Li X, Park J, Stevens TL, Bobbili PJ, Riaz M, Ren Y, Stoddard CE, Janssen PM, Bunch TJ, Hall SP, Lo YC, Jacoby DL, Qyang Y, Wright N, Ackermann MA, Campbell SG.
Ng R, et al. Among authors: ren y.
JCI Insight. 2019 Jun 13;5(14):e128643. doi: 10.1172/jci.insight.128643.
JCI Insight. 2019.
PMID: 31194698
Free PMC article.